手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 多発性硬化症歩行スケール-12 (MSWS-12)× | 多発性硬化症QOL-54 (MSQOL-54)× | |
|---|---|---|
| 分野 | 神経学 | 神経学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2003 | 1995 |
| 提唱者≠ | Jeremy C. Hobart, University of Plymouth | Barbara G. Vickrey, UCLA |
| 種類 | Self-report questionnaire | Self-report questionnaire |
| 原典≠ | Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 60(1), 31-36. DOI ↗ | Vickrey, B. G., Hays, R. D., Genovese, B. J., Myers, L. W., & Ellison, G. W. (1995). Outcomes in Multiple Sclerosis: The Multiple Sclerosis Quality of Life-54 Scale. Health Psychology, 14(1), 34-42. DOI ↗ |
| 別名≠ | MS Walking Scale-12, MSWS | MS QoL-54 |
| 関連≠ | 3 | 4 |
| 概要≠ | The MSWS-12 is a brief, patient-reported outcome measure specifically designed to assess the impact of multiple sclerosis on walking ability and limitation. Developed by Hobart and colleagues in 2003, this 12-item scale captures both the physical difficulty and functional consequences of MS-related gait impairment. It is highly responsive to change and widely used in MS clinical trials and practice as a primary outcome measure for assessing intervention effects on mobility. | The MSQOL-54 is a disease-specific quality-of-life instrument designed to assess the physical and mental burden of multiple sclerosis on patients' daily functioning and well-being. Developed by Vickrey and colleagues in 1995, it combines the widely-used SF-36 generic health questionnaire with 18 MS-specific items to provide comprehensive measurement of QoL in MS populations. This scale is a cornerstone tool in MS clinical research and patient monitoring. |
| ScholarGateデータセット ↗ |
|
|